New Zealand markets close in 6 hours 16 minutes

NRx Pharmaceuticals, Inc. (NRXP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.3800+0.1300 (+10.40%)
At close: 04:00PM EST
1.3800 0.00 (0.00%)
After hours: 04:39PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 77.79M
Enterprise value 38.11M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.64
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.64

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 3-81.29%
S&P500 52-week change 3-13.20%
52-week high 38.0000
52-week low 30.4900
50-day moving average 30.8436
200-day moving average 31.2902

Share statistics

Avg vol (3-month) 3294.79k
Avg vol (10-day) 3619.43k
Shares outstanding 567.64M
Implied shares outstanding 6N/A
Float 839.05M
% held by insiders 144.13%
% held by institutions 17.05%
Shares short (14 Nov 2022) 41.31M
Short ratio (14 Nov 2022) 45.74
Short % of float (14 Nov 2022) 43.46%
Short % of shares outstanding (14 Nov 2022) 41.94%
Shares short (prior month 13 Oct 2022) 41.47M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-155.95%
Return on equity (ttm)-474.37%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -87.42M
Net income avi to common (ttm)-315.74M
Diluted EPS (ttm)-6.2470
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.25M
Total cash per share (mrq)0.27
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.08
Book value per share (mrq)0.25

Cash flow statement

Operating cash flow (ttm)-42.72M
Levered free cash flow (ttm)-78.63M